Jeffrey B. Miller, Esq.

Attorney, Director-in-Charge
(717) 556-1088
280 Granite Run Drive, Suite 310
Lancaster, PA 17601

An experienced health care and life sciences executive and consultant, Jeffrey B. Miller, Esq. is a trusted advisor for clients across the business spectrum, with an emphasis on businesses involved in healthcare and the life sciences, and their supporting service providers and suppliers. Working with clients that range from start-up organizations to large, complex international conglomerates, Jeff collaborates with organizational owners, board members, financial backers (including private equity), executive management and staff of all levels to strategically address corporate governance matters and challenges, risk identification, mitigation and management, information privacy, cyber security, payment, reimbursement and revenue integrity, and corporate ethics and compliance. Jeff’s services focus on improving the effectiveness, quality, integrity, compliance, speed and efficiency of organizational operations, while enhancing company value. An experienced change manager and crisis leader, Jeff also counsels and trains board members and company executives on change management and crisis leadership, strategic planning, project leadership, team building and other key proficiencies necessary to achieve organizational success during times of challenge and transformation. Specific services include:

  • Board and Senior Management Advisory Services; Independent Board Expert
  • Due Diligence (Compliance)
  • Payment and Reimbursement Matters; Revenue Integrity Effectiveness
  • Statistical Analysis and Support Services
  • Consulting Compliance/Privacy/Security Officer Subscription Services
  • Risk Assessment, Management and Mitigation
  • Work Plan Development and Execution
  • Compliance Program Design, Execution, Benchmarking, Assessments, Improvements and Reporting
  • Hotline Reports and Investigations, including Forensic Analysis
  • Comprehensive Quality Assurance Advice and Support, including Root Cause Analysis and Testing
  • Auditing, Monitoring, Identification and Implementation of Corrective/Preventive Actions (Purchasing, Manufacturing, Data Integrity)
  • Information Privacy and Security (including HIPAA/HITECH)
  • Cyber-Security Systems, Platforms and Support
  • Government Agency and Payor Negotiation Strategies and Tactics
  • Implementing and Managing Settlement Agreements, including Corporate Integrity Agreements and Deferred Prosecution Agreements
  • Litigation Support (Commercial and Corporate, Criminal and Civil)
  • E-Discovery and Data Mining
  • IRO and IRO Review Preparation Services
  • Expert Witness Services

As part of Jeff’s services he provides advice and services to organizations involved with government agency or commercial payor legal actions, investigations, audits and reviews, including matters involving the U.S. Department of Justice (DOJ), the Food and Drug Administration (FDA), the Department of Health and Human Services, Office of Inspector General (OIG), and the Office of Civil Rights (OCR), among other federal and state authorities. Further, Jeff assists clients in avoiding potential legal and regulatory entanglements by providing experienced advice and services on the design, development and implementation of effective and efficient legal and regulatory compliance programs that satisfy applicable guidelines while enhancing company operations and value.

Prior to joining Saxton & Stump, Jeff held professional and executive-level positions at healthcare and life sciences companies, including Mercy Health System of Southeastern Pennsylvania, a non-profit regional integrated delivery system, and DermOne, LLC, a multi-state, private equity backed management service organization, where he served as general counsel, and compliance and privacy officer. Jeff served for nearly 10 years as vice president and chief compliance officer for Synthes, a leading international medical device company, which was acquired by Johnson & Johnson in 2012 and combined with DePuy to form The DePuy Synthes Companies, part of the Johnson & Johnson family of companies, the world’s largest orthopedic and neurological businesses. Most recently, he served as a managing director at a financial and economic consulting firm that concentrated in forensics, valuation, intellectual property and performance optimization.

Jeff is regularly invited to present at global, national, regional and local organizations including the U.S. National Academy of the Sciences, the Ethisphere Institute, the American Bar Association, the American Health Lawyers Association, the Health Care Compliance Association, the Society of Corporate Compliance and Ethics and Temple University. He is also a faculty member at the Pennsylvania Bar Institute, the continuing legal education arm of the Pennsylvania Bar Association, where he instructs attorneys and non-attorney compliance officers on transactional, commercial, regulatory and compliance-related topics.

  • Wolters Kluwer, Health Law Advisory Board Member
  • Pennsylvania Bar Association, Member
  • American Health Lawyers Association, Member
  • Institute for Business Ethics, Establishing Member of the European Network of Integrity and Compliance Officers
  • Open Compliance and Ethics Group, Member, GRC capability model task force, 2007 – 2009
  • American Academy of Family Physicians, Member, Panel of Consultants, 2002 – 2004
  • Love INC. of Lancaster County, Board Member
  • Manheim Township Marching Band Boosters, Board Member, 2014 – 2019
  • United Way of Lancaster, Member of the 2-1-1 Volunteer Center Advisory Committee, 2016 – 2017
  • Hunger Free Lancaster County, Service Committee member and Chair of the Volunteer and Event Planning Task Force, 2015 – 2017
  • Junior Achievement of Central Pennsylvania, teacher, 2009 – 2013
  • A Prescription for Compliance Officer Burnout from the Psychoneurotic Institute for the Very, Very Nervous, Wolters Kluwer Legal and Regulatory Solutions U.S. Law & Health Blog, November 2015
  • Strategic Perspectives: Learning from the Past and Building for the Future: Corporate Integrity Agreements in the Life Sciences Industry, Wolters Kluwer Health Law Daily, October 2014
  • No Picnics in the Park for Responsible Corporate Officers: An Update and Overview of Individual Prosecutions in the Life Sciences Industry, Health Care Compliance Letter, Wolters Kluwer, Vol. 14, Issue 6, June 2011
  • The Narrowing Landscape of Manufacturer-Physician Relationships, Physicians News Digest, Physician’s News Digest, Incorporated, July 2009 
  • Teaching Under the Influence? Manufacturer Support of Continuing Medical Education Programs, Health Care Compliance Letter, Wolters Kluwer, Vol. 11, Issue 1, January 2008
  • Keeping Your Friends Close and Your Business Partners Closer: Legal Dynamics in the Relationships Among Hospitals, Physicians and Manufacturers, Health Care Compliance Letter, Wolters Kluwer, Vol. 10, Issue 1, January 2007
  • Risky Business – Advancing Your Assessments and Analyses Beyond that Old Time Rock and Roll, Pennsylvania Bar institute 25th Annual Health Law Institute, March 12, 2020
  • Medical Device Liability – A Case Perspective, National Academy of the Sciences, Biomedical Engineering Materials Applications Roundtable, March 25, 2019
  • Compliance Program Efficiency and Effectiveness, Pennsylvania Bar Institute 23rd Annual Health Law Institute, March 15, 2017
  • Compliance and Conflicts of Interest, Health Care Compliance Association Philadelphia Regional Conference, June 3, 2016
  • A Prescription for Compliance Officer Burnout from the Psychoneurotic Institute for the Very, Very Nervous, Health Care Compliance Association Philadelphia Regional Conference, June 3, 2016
  • The Fundamentals of Designing, Implementing and Maintaining Corporate Compliance Programs, Pennsylvania Bar Institute 22nd Annual Health Law Institute, March 15, 2016
  • Living in the Tempest: Studying Trends in Corporate Integrity Agreements for Better Future Compliance, Pennsylvania Bar Association, Pennsylvania Bar Institute, 20th Annual Health Law Institute, March 13, 2014
  • Ambien Anyone? The Issues that Keep Compliance Officers Awake at Night, American Bar Association, Health Law Section, 15th Annual Conference on Emerging Issues in Healthcare Law, February 28, 2014
  • Highly Regulated Industries, The Ethisphere Institute, 2013 Global Ethics Summit, March 6, 2013
  • The Legal Impact of Misdemeanor Liability and the Responsible Corporate Officer Doctrine, Center for Business Intelligence, Second Annual Life Sciences In-House Legal Counsel Congress, September 21, 2012
  • Implications of FCPA and Ex-U.S. Anti-Corruption Operations – How the Enforcement Environment is Evolving, Center for Business Intelligence, Second Annual Life Sciences In-House Legal Counsel Congress, September 21, 2012
  • Ethics as Organizational Culture; Government as Stakeholders, Temple University, Fox School of Business and Management, March 2010
  • Adjunct Professor, Villanova University Charles Widger School of Law
  • Faculty Member, Pennsylvania Bar Institute
  • Yale University School of Management, Rising Star of Corporate Governance Award, 2008
  • Provided insight, coaching, mentoring and support services to boards of directors, senior executives, management teams and staff in the healthcare and life sciences industries, with a focus on start-ups though middle-market companies
  • Supported organizations through transition periods including preparation for mergers and acquisitions, expansions, downsizings and the integration of complex functional and business operations
  • Developed and executed compliance, privacy, security and workplace safety programs
  • Designed, built and implemented improvements to a company’s revenue cycle process, including their Merit-Based Incentive Payment System (MIPS) for eligible physicians
  • Led an international dental implant company to develop and implement practices to bring it into compliance with its Foreign Corrupt Practices Act (FCPA) Deferred Prosecution Agreement (DPA), after more than one year of non-compliance. Analyzed, redesigned and developed a global anti-corruption program to increase the effectiveness, breadth, depth, speed and efficiency of internal processes and controls.
  • Developed and implemented a contracting process and system that was adopted by a national non-profit integrated health system
  • Designed, built and led global compliance function program from scratch – designed, developed and led compliance infrastructures, processes, activities and staff worldwide
  • Prepared and led the compliance function program through a $2.1 billion acquisition
  • Supported organizations through periods of transition, including preparing for and managing through M&A-related activities, expansions, downsizing, and the integration of complex functional and business operations
  • Assessed and mitigated risks through the design and implementation of more than 15 long-term care compliance programs, including some of the first anti-corruption compliance programs for long-term care facilities in Pennsylvania